Literature DB >> 23942434

Locked-in syndrome as a presentation of snakebite.

Chandrika Azad1, Vidushi Mahajan, Kana Ram Jat.   

Abstract

Snake bite is a common condition in tropical countries. Neurotoxic features of snake bite vary from early morning neuroparalytic syndrome to various cranial nerve palsies. Locked in syndrome (LIS) is a rare presentation. We present four children that had LIS; three patients had total and one had incomplete LIS. All patients made successful recovery with polyvalent anti-snake venom and supportive management. This case series highlights the importance of early diagnosis of LIS in snake bite.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23942434     DOI: 10.1007/s13312-013-0174-1

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  5 in total

1.  Brain Dead Presentation of Snake Bite.

Authors:  Sonika Agarwal; Nidhi Kaeley; Sushant Khanduri; Nand Kishore
Journal:  Indian J Crit Care Med       Date:  2018-07

2.  Dramatic neuromuscular paralysis following occult snakebites: An awareness for the primary care physician.

Authors:  Vishal Mehta; Ritesh Kumar; Rathod Prabhakar; Chandra B Sharma; Aneesha Thomas
Journal:  J Family Med Prim Care       Date:  2022-01-31

3.  Neurotoxin envenomation mimicking brain death in a child: A case report and review of literature.

Authors:  Madhu Dayal; Smita Prakash; Pradeep K Verma; Mridula Pawar
Journal:  Indian J Anaesth       Date:  2014-07

4.  Neuromuscular Effects of Common Krait (Bungarus caeruleus) Envenoming in Sri Lanka.

Authors:  Anjana Silva; Kalana Maduwage; Michael Sedgwick; Senaka Pilapitiya; Prasanna Weerawansa; Niroshana J Dahanayaka; Nicholas A Buckley; Christopher Johnston; Sisira Siribaddana; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2016-02-01

Review 5.  Toxicologic Confounders of Brain Death Determination: A Narrative Review.

Authors:  Lauren Murphy; Hannah Wolfer; Robert G Hendrickson
Journal:  Neurocrit Care       Date:  2020-09-30       Impact factor: 3.532

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.